This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Milla, C. Articles by Moran, A. Search for Related Content PubMed PubMed Citation Articles by Milla, C. Articles by Moran, A. Social Bookmarking                         What's this?

Glycemic Response to Dietary Supplements in Cystic Fibrosis is Dependent on the Carbohydrate Content of the Formula

Departments of Pediatrics and the Clinical Research Center, University of Minnesota, Minneapolis

Leah Doherty, RN

Departments of Pediatrics and the Clinical Research Center, University of Minnesota, Minneapolis

Susan Raatz, MS, RD

Departments of Pediatrics and the Clinical Research Center, University of Minnesota, Minneapolis

Sarah Jane Schwarzenberg, MD

Departments of Pediatrics and the Clinical Research Center, University of Minnesota, Minneapolis

Warren Regelmann, MD

Departments of Pediatrics and the Clinical Research Center, University of Minnesota, Minneapolis

Antoinette Moran, MD

Departments of Pediatrics and the Clinical Research Center, University of Minnesota, Minneapolis

Background: Enteral formula feedings are frequently prescribed to cystic fibrosis (CF) patients to boost caloric intake. A substantial number of these patients are glucose intolerant and have severe respiratory compromise. Methods: To determine the effect of the carbohydrate content on glucose tolerance and respiratory function in glucose-intolerant CF patients with poor lung function, we examined the response to bolus feedings of five dietary supplements: a high-fat formula developed in our Clinical Research Center (CRC), Pulmocare, a high-carbohydrate formula developed in our CRC, Ensure Plus, and sugar-free Scandishake. Results: Glucose excursion in response to the formulas with the lowest carbohydrate content was significantly less than that found in response to formulas with higher carbohydrate content. Insulin levels were also markedly lower in response to the low-carbohydrate high-fat formulas. Glucose excursion, expressed as a percent of the response to the CRC high-fat formula, was 111% ± 12% for Pulmocare (p = NS), 202% ± 34% for Ensure Plus (p < .01), 227% ± 37% for CRC high carbohydrate (p = .001), and 357% ± 33% for sugar-free Scandishake (p < .001). CO₂ production, O₂ consumption, minute ventilation, and respiratory rate increased modestly but not significantly in response to all formulas. No significant differences were found between the formulas in regards to these parameters. There were no subjective complaints of dyspnea during any of the five studies. Conclusion: The carbohydrate content of liquid dietary supplements appears to be an important determinant of hyperglycemia in glucose-intolerant adult CF patients. (Jouynal of Parenteral and Enteral Nutrition 20:182-186, 1996)

Journal of Parenteral and Enteral Nutrition, Vol. 20, No. 3, 182-186 (1996)
DOI: 10.1177/0148607196020003182


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?